Empower Clinics Inc announced that it has signed a partnership agreement with Alp Medtech AG, the authorized representative of European medical device company Atlas Medical Gmbh, to focus on the US market with immediate sales and marketing of US government-approved products and laboratory collaboration to secure further Food and Drug Administration (FDA) approvals.
The Vancouver-based integrated healthcare company said the partnership agreement includes:
- Distribution rights by Empower for Atlas products in the US, Canada, Mexico, Central America, Australia, New Zealand;
- Sales and marketing launch of current FDA approved Atlas products in US;
- Utilization of MediSure Laboratory to seek FDA approvals for Atlas products;
- Ongoing clinical study services by Empower's MediSure Laboratory for FDA approval of Atlas products;
- Support by Empower for Atlas and its partners to set up future US manufacturing and;
- Potential investment by Atlas and its partners to support Empower's growth plan.
“Together we can generate short term revenues as a number of Atlas products are already FDA approved and only require sales and marketing support from Empower and our subsidiaries,” Empower Clinics CEO Steven McAuley said in a statement.
READ: Empower Clinics announces closing of private placement, resignation of auditor and leadership transition at MediSure Canada
“Our longer-term collaboration can also drive further growth in the US as together we secure US FDA approvals for more Atlas products by leveraging our diagnostics laboratory and medical team for clinical studies,” McAuley added.
Atlas Medical specializes in the distribution and manufacturing of invitro diagnostic tests and medical devices, according to the company.
Empower Clinics is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories.
Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. The company's Health and Wellness and Diagnostics and Technology business units are positioned to positively impact the integrated health of its patients, while simultaneously providing long-term value for shareholders.
Contact Sean at sean@proactiveinvestors.com